MBRX SCHEDULE 13D: Activist campaign

A Schedule 13D was

Filed with the SEC on · accession 0001437749-26-028927

MBRX filed a SCHEDULE 13D (schedule 13d) with the SEC on Aug 25, 2026. A Schedule 13D was filed on 2026-08-25 disclosing a beneficial ownership position in Moleculin Biotech, Inc. (MBRX). The stock moved +0.3% by the first close after the filing.

Summary of the filing

A Schedule 13D was filed on 2026-08-25 disclosing a beneficial ownership position in Moleculin Biotech, Inc. (MBRX). The filing indicates the reporting person holds more than 5% of the company and may have plans or proposals regarding the issuer.

Key details

Issuer/subject companyMoleculin Biotech, Inc.

How MBRX stock reacted

Close before

$12.19

Aug 24, 2026

First close after

+0.28%

$12.22

5 trading days

+5.81%

$12.89

Since filing

-28.61%

$8.70

✦ Ask GOAX AI about this filing — what it means for MBRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MBRX?

Click here

Frequently asked questions

What did MBRX file with the SEC on Aug 25, 2026?

MBRX filed a SCHEDULE 13D (Activist campaign). A Schedule 13D was filed on 2026-08-25 disclosing a beneficial ownership position in Moleculin Biotech, Inc. (MBRX). The filing indicates the reporting person holds more than 5% of the company and may have plans or proposals regarding the issuer.

What does a activist campaign mean for MBRX stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).

How did MBRX stock react to this filing?

MBRX closed at $12.19 before the filing and $12.22 on Aug 25, 2026 (+0.28%). Five trading days later: $12.89 (+5.81%).

Other MBRX SEC filings

Get alerts when MBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days